Showing results (1-10 of 833) with videos related to
Sort By:
Pageof 84
Trends in Cancer|December 21, 2023
Harnessing CD8 T cell responses using PD-1-IL-2 combination therapyMasao Hashimoto, Suresh S Ramalingam, Rafi AhmedAnnual Review of Medicine|February 8, 2018
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for InterventionsMasao Hashimoto, Alice O Kamphorst, Se Jin Im, et al.Cancer Journal (Sudbury, Mass.)|March 22, 2019
Repurposing Food and Drug Administration-Approved Drugs to Promote Antitumor ImmunityVidula V Sukhatme, Suresh S Ramalingam, Rafi Ahmed, et al.Cold Spring Harbor Perspectives in Biology|November 5, 2017
Cytokine-Mediated Regulation of CD8 T-Cell Responses During Acute and Chronic Viral InfectionMasao Hashimoto, Se Jin Im, Koichi Araki, et al.The Journal of Clinical Investigation|November 15, 2022
mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infectionSatomi Ando, Charles M Perkins, Yamato Sajiki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2010
Lung cancer in HIV-positive patientsSuchita Pakkala, Suresh S RamalingamCurrent Opinion in Oncology|January 26, 2016
Adjuvant therapy for nonsmall cell lung cancer: recent advances and future perspectivesSuchita Pakkala, Suresh S RamalingamClinical Lung Cancer|April 14, 2009
Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapySuchita Pakkala, Suresh S RamalingamHematology/Oncology Clinics of North America|December 4, 2016
Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment ParadigmSuchita Pakkala, Suresh S RamalingamFrontiers in Oncology|December 24, 2025
Rapidly evolving therapeutic advances for classical EGFR-mutant NSCLCKelsey Pan, Suresh S RamalingamPageof 84